Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › NOX2 as a biomarker of radiotherapy efficiency in cancer patients

NOX2 as a biomarker of radiotherapy efficiency in cancer patients

US Patent 11603568 · Granted Mar 14, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for training a decision system for segmenting medical images2025
Use of minaprine to reduce tumor growth2022
Use of minaprine to reduce tumor growth2022
Enhancers of cellular cannibalism for use to sensitize tumors to radiation thera2022
Enhancers of cellular cannibalism for use to sensitize tumors to radiation thera2022
Process for the preparation of freeze-dried 2-[(3-aminopropyl)amino] ethanethiol2021
Simultaneous detection of cannibalism and senescence as prognostic marker for ca2021
Simultaneous detection of cannibalism and senescence as prognostic marker for ca2021
Methods and pharmaceutical compositions for treating human immunodeficiency viru2018
Methods and pharmaceutical compositions for treating human immunodeficiency viru2018
Simultaneous detection of cannibalism and senescence as prognostic marker for ca2017
Simultaneous detection of cannibalism and senescence as prognostic marker for ca2017